Related Experiment Video
Updated: Jun 5, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.2K
Association Between Video-Based Telemedicine Visits and Medication Adherence Among Patients With Heart Failure:
Yaguang Zheng1, Samrachana Adhikari2, Xiyue Li2
1New York University Rory Meyers College of Nursing, 433 1st Avenue, New York, NY, 10010, United States, 1 212-998-5170.
JMIR Cardio
|December 5, 2024
Summary
Telemedicine visits for heart failure patients showed similar medication adherence rates compared to in-person visits. This suggests telemedicine is a viable option for maintaining adherence, offering convenience and overcoming transportation barriers.
Area of Science:
- Cardiology
- Health Services Research
- Digital Health
Background:
- The COVID-19 pandemic accelerated telemedicine adoption in clinical practice.
- Medication adherence in heart failure patients via telemedicine remains understudied.
- Understanding telemedicine's impact on adherence is crucial for heart failure management.
Purpose of the Study:
- To compare medication adherence between telemedicine and in-person visits for heart failure patients.
- To assess the association between visit type and medication adherence rates.
Main Methods:
- Retrospective cross-sectional study of 9521 adult heart failure patients (April 1 - October 1, 2020).
- Medication adherence measured by Proportion of Days Covered (PDC) within 180 days (adherent if PDC ≥0.8).
- Patients categorized into telemedicine-only or in-person-only groups; Poisson and logistic regression used.
Main Results:
- No significant difference in mean PDC between telemedicine (0.794) and in-person (0.812) groups (Rate Ratio 0.99, P=.09).
- Similar adherence rates: 69% for telemedicine vs. 71.6% for in-person visits (Odds Ratio 0.94, P=.12).
- Findings consistent after adjusting for covariates like age, sex, race, and insurance.
Conclusions:
- Telemedicine visits are associated with comparable medication adherence rates to in-person visits for heart failure patients.
- Provides real-world evidence supporting telemedicine as an effective outpatient care method for heart failure.
- Telemedicine offers a convenient alternative for maintaining medication adherence, addressing potential transportation challenges.
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
01:26Heart Failure Drugs: Inotropic Agents
517
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
517
01:28Mitral Regurgitation IV: Nursing Management
2
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
2
01:20Rheumatic Heart Disease IV: Nursing Management
3
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
3